Susvimo 100 mg/mL injection Images
Generic Name: ranibizumab
This medication has been identified as Susvimo 100 mg/mL injection. It is supplied by Genentech, Inc.
Susvimo is used in the treatment of Macular Degeneration and belongs to the drug class anti-angiogenic ophthalmic agents. Risk cannot be ruled out during pregnancy. Susvimo 100 mg/mL injection is not a controlled substance under the Controlled Substances Act (CSA).
Images of medication
Susvimo
- Generic Name
- ranibizumab
- Strength
- 100 mg/mL injection
- Availability
- Prescription only
- Drug Class
- Anti-angiogenic ophthalmic agents
- Pregnancy Category
- C - Risk cannot be ruled out
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Genentech, Inc.
- National Drug Code (NDC)
- 50242-0078
More about Susvimo (ranibizumab ophthalmic)
- Check interactions
- Compare alternatives
- Pricing & coupons
- Drug images
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: anti-angiogenic ophthalmic agents
- Breastfeeding
- En español
Patient resources
Other brands
Professional resources
Other brands
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
